Continuation of research and development activities
First written in FY2017-Q1. 20 of 34 entries say "Restated". Latest entry: FY2026.
56 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The group had a total of 143 R&D personnel, and R&D expenses for the current consolidated fiscal year were ¥2,647 million. After deducting income from prototypes, contract research and other sources (¥801 million), R&D expenses were ¥1,845 million, equivalent to 5.19% of consolidated net sales.」
The company had 143 R&D personnel, and total R&D expenses increased to ¥2,647 million, while R&D expenses after deducting income increased to ¥1,845 million. - 2026-05-15AdvancedResults
「Research and development expenses 1,550 1,845」
Research and development expenses increased from ¥1,550 million in the previous period to ¥1,845 million. - FY2026-H1Increase in R&D expensesAnnual report
「The group's total R&D expenses for the current interim consolidated accounting period were ¥901 million.」
R&D activities continued, and R&D expenses increased from ¥703 million in the same interim period of the previous year to ¥901 million. - FY2025AdvancedAnnual report
「The group had a total of 133 R&D personnel, and R&D expenses for the current consolidated fiscal year were ¥2,327 million. After deducting income from prototypes, contract research and other sources (¥776 million), R&D expenses were ¥1,550 million, equivalent to 4.50% of consolidated net sales.」
The company disclosed 133 R&D personnel, R&D expenses of ¥2,327 million, R&D expenses of ¥1,550 million after deducting income, and 4.50% of net sales. This was an increase from the previous year's ¥1,377 million after deducting income, and the R&D structure, including the New Business Development Group, has also been defined in greater detail. - FY2025-H1Increase in R&D expensesAnnual report
「The group's total R&D expenses for the current interim consolidated accounting period were ¥703 million.」
R&D activities continued, and R&D expenses increased from ¥659 million in the same interim period of the previous year to ¥703 million. - FY2024AdvancedAnnual report
「Research and development expenditure for the current consolidated fiscal year was ¥2,128 million, while research and development costs after deducting income from prototypes, contract research and other sources (¥750 million) were ¥1,377 million (4.09% of consolidated sales).」
The company disclosed 124 R&D personnel, total R&D expenses of ¥2,128 million, and R&D expenses of ¥1,377 million after deducting income. It has established a New Business Development Group and other units within the Development Headquarters and has also defined its R&D structure in greater detail. - FY2024-Q3Increase in R&D expensesAnnual report
「The Group's total research and development expenditure for the third quarter of the current consolidated cumulative period was ¥989 million.」
Research and development activities continued, and research and development expenditure was ¥989 million, up from ¥622 million in the same period of the previous year. - FY2024-Q2Increase in R&D expensesAnnual report
「The Group's total research and development expenditure for the second quarter of the current consolidated cumulative period was ¥659 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the current consolidated cumulative period.」
Research and development activities continued, and research and development expenditure was ¥659 million, up from ¥315 million in the same period of the previous year. - FY2024-Q1RestatedAnnual report
「Group-wide R&D expenses for the first quarter of the fiscal year totaled ¥350 million. There were no material changes in the group's R&D activities during the first quarter of the fiscal year.」
Research and development activities continued, with research and development expenditure of ¥350 million disclosed for the first quarter cumulative period. - FY2023AdvancedAnnual report
「The research and development structure for the current consolidated fiscal year places, under the Development Division of the iCas Company, the Component Development Group, responsible for development centered on processing technologies; the Adhesive and Bonding Development Group, responsible for development centered on pressure-sensitive adhesive and bonding technologies; the Functional Paper Development Group, responsible for development centered on papermaking technologies; the New Technology Promotion Group, responsible for developing new technologies; the Technical Research Institute, responsible for exploring elemental technologies; and the Intellectual Property Group, responsible for accumulating and managing the technologies developed. The structure promotes the exchange of personnel and technologies within the Company, accelerates new product development by fostering the integration of technologies and expertise held by each development division, and manages and utilizes those technologies as assets.」
The Company detailed its research and development structure, disclosing 130 research and development personnel, research and development expenditure of ¥1,794 million, and research and development costs of ¥931 million after deducting prototype and other income (2.72% of consolidated sales). It also reported achievements including product expansion, applied development and commercialization studies in the Toner, Electronic Materials, Functional Paper, Security Media and New Development fields. - FY2023-Q3Increase in R&D expensesAnnual report
「The Group's total research and development expenditure for the third quarter of the current consolidated cumulative period was ¥622 million.」
Research and development activities continued, and research and development expenditure was ¥622 million, up from ¥400 million in the same period of the previous year. - FY2023-Q2Increase in R&D expensesAnnual report
「The Group's total research and development expenditure for the second quarter of the current consolidated cumulative period was ¥315 million.」
Research and development activities continued, with research and development expenditure of ¥315 million disclosed. This was up from ¥251 million in the same period of the previous year. - FY2023-Q1RestatedAnnual report
「The Group's total research and development expenditure for the first quarter of the current consolidated cumulative period was ¥153 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
Research and development activities continued, with research and development expenditure of ¥153 million disclosed for the first quarter cumulative period. There were no material changes in the status of the activities. - FY2022-Q3RestatedAnnual report
「The Group's total research and development expenditure for the third quarter of the current consolidated cumulative period was ¥400 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the current consolidated cumulative period.」
Research and development activities continued, with research and development expenditure of ¥400 million disclosed for the third quarter cumulative period. - FY2022-Q2RestatedAnnual report
「The Group's total research and development expenditure for the second quarter of the current consolidated cumulative period was ¥251 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the current consolidated cumulative period.」
Research and development activities continued, with research and development expenditure of ¥251 million disclosed for the second quarter cumulative period. - FY2022-Q1RestatedAnnual report
「The Group’s total R&D expenses for the cumulative first quarter were ¥162 million. There were no material changes in the status of the Group’s R&D activities during the cumulative first quarter.」
Research and development activities continued, with research and development expenditure of ¥162 million disclosed for the first quarter cumulative period. - FY2021-Q3RestatedAnnual report
「The Group's total research and development expenditure for the third quarter of the current consolidated cumulative period was ¥597 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the current consolidated cumulative period.」
Research and development activities continued, with research and development expenditure of ¥597 million disclosed for the third quarter cumulative period. - FY2021-Q2RestatedAnnual report
「The Group's total research and development expenditure for the second quarter of the current consolidated cumulative period was ¥452 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the current consolidated cumulative period.」
Research and development activities continued, with research and development expenditure of ¥452 million disclosed for the second quarter cumulative period. There were no material changes in the status of the activities. - FY2021-Q1RestatedAnnual report
「The Group's total research and development expenditure for the first quarter of the current consolidated cumulative period was ¥233 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
Research and development activities continued, with research and development expenditure of ¥233 million disclosed for the first quarter cumulative period. - FY2020AdvancedAnnual report
「The main achievements during the current consolidated fiscal year included the commercialization of new high-performance films for displays and adhesive-coated products, expansion of products related to optical fiber systems, progress in developing new adhesive materials related to electronic materials, and, for toners for various multifunction printers and printers, expansion of the color toner lineup and establishment of production technologies.」
In addition to continuing research and development activities, the Company reported achievements including the commercialization of high-performance films and adhesive-coated products, progress in developing new adhesive materials, expansion of the toner lineup, and establishment of production technologies. - FY2020-Q3RestatedAnnual report
「The Group's total research and development expenditure for the third quarter of the current consolidated cumulative period was ¥737 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the current consolidated cumulative period.」
Research and development activities continued, with research and development expenditure of ¥737 million disclosed for the third quarter cumulative period. There were no material changes in the status of the activities. - FY2020-Q2RestatedAnnual report
「The Group's total research and development expenditure for the second quarter of the current consolidated cumulative period was ¥498 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the current consolidated cumulative period.」
Research and development activities continued, with research and development expenditure of ¥498 million disclosed for the second quarter cumulative period. There were no material changes in the status of the activities. - FY2020-Q1RestatedAnnual report
「The Group's total research and development expenditure for the first quarter of the current consolidated cumulative period was ¥246 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
Research and development activities continued, with research and development expenditure of ¥246 million disclosed for the first quarter cumulative period. There were no material changes in the status of the activities. - FY2019AdvancedAnnual report
「The main achievements during the current consolidated fiscal year included the commercialization of new high-performance films for displays and adhesive-coated products, expansion of products related to optical fiber systems, progress in developing new adhesive materials related to electronic materials, and, for toners for various multifunction printers and printers, expansion of the color toner lineup and establishment of production technologies. … Research and development expenditure for the current consolidated fiscal year was ¥1,043 million (3.1% of consolidated sales).」
In addition to continuing research and development activities, the Company reported full-year achievements including the commercialization of high-performance films and other products, expansion of the toner lineup, and establishment of production technologies. - FY2019-Q3RestatedAnnual report
「The Group's total research and development expenditure for the third quarter of the current consolidated cumulative period was ¥832 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the current consolidated cumulative period.」
Research and development activities continued, with research and development expenditure of ¥832 million disclosed for the third quarter cumulative period. There were no material changes in the status of the activities. - FY2019-Q2RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the cumulative second quarter of the current consolidated fiscal year was ¥586 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
Research and development activities continued, with research and development expenditure of ¥586 million disclosed for the second quarter cumulative period. - FY2019-Q1RestatedAnnual report
「The Group's total research and development expenditure for the first quarter of the current consolidated cumulative period was ¥310 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
Research and development activities continued, with research and development expenditure of ¥310 million disclosed for the first quarter cumulative period. - FY2018-Q3RestatedAnnual report
「The Group's total research and development expenditure for the third quarter of the current consolidated cumulative period was ¥822 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the current consolidated cumulative period.」
Research and development activities continued, with research and development expenditure of ¥822 million disclosed for the third quarter cumulative period. There were no material changes in the status of the activities. - FY2018-Q2RestatedAnnual report
「The Group's total research and development expenditure for the second quarter of the current consolidated cumulative period was ¥513 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the current consolidated cumulative period.」
Research and development activities continued, with research and development expenditure of ¥513 million disclosed for the second quarter cumulative period. There were no material changes in the status of the activities. - FY2018-Q1RestatedAnnual report
「The Group's total research and development expenditure for the first quarter of the current consolidated cumulative period was ¥255 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
Research and development activities continued, with research and development expenditure of ¥255 million disclosed for the first quarter cumulative period. - FY2017RestatedAnnual report
「Under the slogan "A development-oriented company in which everyone participates," the Company is actively pursuing the development of new products and technologies for the future. … Research and development expenditure for the current consolidated fiscal year was ¥950 million (2.9% of consolidated sales).」
Research and development activities continued, with a company-wide development structure and annual research and development expenditure of ¥950 million, equivalent to 2.9% of consolidated sales, disclosed. - FY2017-Q3RestatedAnnual report
「The Group's total research and development expenditure for the third quarter of the current consolidated cumulative period was ¥723 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the current consolidated cumulative period.」
Research and development activities continued, with research and development expenditure of ¥723 million disclosed for the third quarter cumulative period. There were no material changes in the status of the activities. - FY2017-Q2RestatedAnnual report
「The Group's total research and development expenditure for the second quarter of the current consolidated cumulative period was ¥484 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the current consolidated cumulative period.」
Research and development activities continued, with ¥484 million disclosed for the second quarter cumulative period. - FY2017-Q1First statedAnnual report
「The Group’s total R&D expenses for the first quarter of the fiscal year were ¥244 million. There were no material changes in the status of the Group’s R&D activities during the first quarter.」
Research and development activities continued, with ¥244 million disclosed for the cumulative period.